A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea‐predominant irritable bowel syndrome
Top Cited Papers
Open Access
- 26 March 2003
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 17 (7) , 895-904
- https://doi.org/10.1046/j.1365-2036.2003.01543.x
Abstract
Aim : To investigate the effects of a probiotic formulation, VSL#3, on gastrointestinal transit and symptoms of patients with Rome II irritable bowel syndrome with predominant diarrhoea. Methods : Tw...Keywords
This publication has 31 references indexed in Scilit:
- Probiotics in the Management of Irritable Bowel Syndrome: A Review of Clinical TrialsMicrobial Ecology in Health & Disease, 2001
- Lactobacillus GG Administered in Oral Rehydration Solution to Children with Acute Diarrhea: A Multicenter European TrialJournal of Pediatric Gastroenterology and Nutrition, 2000
- Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5‐HT3 receptor antagonistAlimentary Pharmacology & Therapeutics, 1999
- Stool Form Scale as a Useful Guide to Intestinal Transit TimeScandinavian Journal of Gastroenterology, 1997
- An Office Guide to Whole-Gut Transit TimeJournal of Clinical Gastroenterology, 1994
- Defecation frequency and timing, and stool form in the general population: a prospective study.Gut, 1992
- Towards a less costly but accurate test of gastric emptying and small bowel transitDigestive Diseases and Sciences, 1991
- How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form.Gut, 1991
- Irritable bowel syndrome: relationship of disorders in the transit of a single solid meal to symptom patterns.Gut, 1983
- Remarks on Zeros and Ties in the Wilcoxon Signed Rank ProceduresJournal of the American Statistical Association, 1959